CD68 and neoplasm: CD68 staining analysed alone correlated to clinical characteristics for more aggressive tumors (e.g., higher T and N status) and an unfavourable prognosis, whereas HLA-DR staining in stromal cells had no impact on patients’ outcome or tumor characteristics (data not shown).